Search results

Jump to navigation Jump to search
Results 1 – 250 of 335
Advanced search

Search in namespaces:

  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  

  • Dosage (category Responsible drug use)
    flexiweigh_balance_accuracy.pdf Scales - TripSit wiki  3-MeO-PCP - TripSit wiki  Responsible drug use index
    5 KB (1,438 words) - 23:18, 21 April 2024
  • Responsible drug use (category Responsible drug use)
    June 16, 2013.  Sharing Drug “Snorting Straws” Spreads Hepatitis C, 2016  Responsible drug use index
    37 KB (3,944 words) - 23:17, 21 April 2024
  • Research chemicals (redirect from Designer drug) (category Responsible drug use)
    (N-Ethylamphetamine) Fencamine Lefetamine MDPV MDPHP Responsible use Research chemical (Wikipedia) Designer drug (Wikipedia) Experimental & Research Chemicals
    19 KB (2,209 words) - 23:08, 21 April 2024
  • Experience index (category PsychonautWiki)
    Progression of Sleep Deprivation Visuals Over Time by Fishcenternicole Edit Responsible use Psychoactive substance index Subjective effects index
    2 KB (4,008 words) - 23:00, 21 April 2024
  • 25x-NBOMe
    25x-NBOMe series are not habit-forming and the desire to use them can actually decrease with use. They are thought to be most often self-regulating. Tolerance
    6 KB (1,847 words) - 00:06, 16 May 2024
  • PCP
    Erowid Experience Vaults: PCP Further information: Responsible use § Hallucinogens The long-term use of PCP may lead to schizophrenia-like psychotic episodes
    25 KB (3,130 words) - 14:33, 16 April 2024
  • 25I-NBOMe
    one use harm reduction practices when using this substance. 25I-NBOMe is not habit-forming and the desire to use it can actually decrease with use. It
    28 KB (4,417 words) - 14:00, 16 April 2024
  • 3-MeO-PCE
    and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational 3-MeO-PCE use do not seem to have been
    20 KB (2,787 words) - 17:34, 17 March 2024
  • 25D-NBOMe
    therapeutic index. 25D-NBOMe has no history of human use prior to being sold online as a designer drug in 2010.[citation needed] Extremely little is known
    19 KB (3,278 words) - 19:48, 19 July 2022
  • 25N-NBOMe
    that one use harm reduction practices when using this drug. 25N-NBOMe is not habit-forming, and the desire to use it can actually decrease with use. It is
    18 KB (3,141 words) - 20:58, 19 July 2022
  • 4-FA
    [citation needed] Virginia: 4-FA is classified as a Schedule I drug.[citation needed] Responsible use Research chemical Entactogen Stimulants Amphetamine MDMA 3-FEA
    21 KB (3,439 words) - 15:42, 30 July 2022
  • Dosage measurement (category Responsible drug use)
    Psychoactives Vault : Basics: The Importance of Measured Doses  Responsible drug use index
    9 KB (1,092 words) - 23:18, 21 April 2024
  • 25B-NBOMe
    substance may be overly difficult to use safely. Therefore it is highly advised to use harm reduction practices if using this substance. 25B-NBOMe or 2C-B-NBOMe
    19 KB (3,287 words) - 22:22, 19 July 2022
  • 25C-NBOMe
    one use harm reduction practices when using this substance. 25C-NBOMe is not habit-forming, and the desire to use it can actually decrease with use. It
    26 KB (4,063 words) - 23:35, 21 April 2024
  • Reagent testing kits (category Responsible drug use) (section How to use reagents)
    that a drug is safe. No drug use is 100% safe. Make wise decisions and take responsibility for your health and well-being; no one else can. Drug checking
    23 KB (1,192 words) - 17:50, 19 March 2024
  • PCE
    Research chemicals § Toxicity and harm potential, and Responsible use § Hallucinogens The long-term use of PCE may lead to schizophrenia-like psychotic episodes
    18 KB (2,543 words) - 21:36, 21 July 2022
  • Main Page (section Responsible drug use)
    classification ⋅ Dosage measurement ⋅ Dosage (Milligram scale) ⋅ Drug overdose ⋅ Drug withdrawal ⋅ HPPD ⋅ List of pharmaceuticals ⋅ Recovery position ⋅
    21 KB (1,004 words) - 23:38, 13 May 2024
  • 3-HO-PCP
    and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational 3-HO-PCP use have not been studied in
    20 KB (2,510 words) - 17:29, 17 March 2024
  • 3-HO-PCE
    and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational 3-HO-PCE use has not been studied in
    16 KB (2,138 words) - 20:47, 21 July 2022
  • Cannabinoid
    carcinogenic. It is strongly recommended that one use harm reduction practices when using these drugs. Please be aware that pre-mixed, branded blends are
    27 KB (3,598 words) - 22:59, 21 April 2024
  • Isomer
    homochiral compound. Responsible use Scientific information Psychoactive substance index Isomer (Wikipedia) https://en.wikipedia.org/wiki/Racemic_mixture |
    7 KB (957 words) - 23:08, 21 April 2024
  • 2C-B
    test. Further information: Responsible use § Hallucinogens The toxicity and long-term health effects of recreational 2C-B use have not been studied in any
    36 KB (4,745 words) - 16:35, 7 April 2024
  • Amphetamine
    amphetamine use, but is unlikely to arise from typical medical use. Tolerance to many of the effects of amphetamine develops with prolonged and repeated use. This
    41 KB (5,610 words) - 19:01, 7 April 2024
  • MDMA (category Pages with citations using unsupported parameters)
    a license from the Drug Enforcement Administration (DEA). Czech Republic: MDMA is a Schedule I controlled substance. Responsible use Entactogen Stimulant
    85 KB (10,499 words) - 14:24, 16 April 2024
  • Synthetic cannabinoid
    disorders not use synthetic cannabinoids. In contrast to most other recreational drugs, the dramatic psychotic state induced by the use of synthetic cannabinoids
    20 KB (2,224 words) - 22:50, 21 April 2024
  • Methamphetamine (category Pages using citations with accessdate and no URL)
    Class A drug as of 18 January 2007. United States: Methamphetamine is a Schedule II controlled substance in the United States. Responsible use Psychoactive
    41 KB (5,798 words) - 13:29, 16 April 2024
  • 3-MeO-PCP
    and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational 3-MeO-PCP use has not been studied in
    25 KB (3,520 words) - 21:44, 6 May 2024
  • Datura
    legitimate medical purposes, a person may not possess or use the plant known as Datura stramonium Responsible use Deliriant Entheogen Tropane alkaloids Diphenhydramine
    26 KB (2,932 words) - 14:16, 16 April 2024
  • Lorazepam
    -bad7-eec855d6162a.pdf Drugs licensing  Drug Scheduling, DEA | https://www.dea.gov/drug-information/drug-scheduling Polish wiki about controlled substances
    22 KB (2,595 words) - 13:26, 16 April 2024
  • 6-APB
    § Toxicity and harm potential, and Responsible use § Hallucinogens Due to only having a short history of human use, the toxicity and harm potential is
    33 KB (4,870 words) - 14:34, 16 April 2024
  • Atropa belladonna
    dangerous and extremely unpleasant experiences. Please use responsible use practices when trying this drug and always have a trip sitter. Atropa belladonna,
    1 KB (155 words) - 14:48, 3 October 2020
  • Thebaine
    listed as a Class A drug under the Misuse of Drugs Act 1971 in the United Kingdom, is controlled as an analog of a Schedule II drug per the Analog Act in
    6 KB (900 words) - 21:25, 29 March 2021
  • MDPV
    strongly recommended that one use harm reduction practices when using this drug. More so than other stimulants, the chronic use of MDPV can be considered highly
    23 KB (3,267 words) - 23:45, 21 April 2024
  • DMT
    to delay or decline the consumption of the drug. It's discouraged to users to make use of anxyolitic drugs to inhibe this effect since the experience can
    58 KB (7,681 words) - 22:15, 14 May 2024
  • Etizolam
    of stopping use abruptly. Due to its high abuse and addiction potential, it is highly advised to use proper harm reduction practices if using this substance
    30 KB (3,506 words) - 14:22, 16 April 2024
  • Experience:60mg 4-AcO-DMT Nonstop Quasi-Orgasmic Objectless Euphoria
    would like to attribute to the fact that I use these substances in far more healthy, balanced and responsible way than I have in times past. The main duration
    7 KB (1,138 words) - 01:16, 8 February 2020
  • 4-FMA
    strongly recommended that one use harm reduction practices when using this substance. As with other stimulants, the chronic use of 4-FMA can be considered
    21 KB (3,467 words) - 16:14, 30 July 2022
  • Flunitrazepam
    alcohol or opioids. It is strongly recommended that one use harm reduction practices when using this drug. The oral LD50 (lethal dose in 50% of the population)
    22 KB (2,689 words) - 20:55, 7 April 2024
  • Special Content Project (category PsychonautWiki)
    of right now. Erowid Bluelight Wiki Tripsit PiHKAL (Online Edition) TiHKAL (Online Edition) Google (i.e. search "xxx drug site:bluelight.org" for better
    7 KB (894 words) - 01:33, 15 April 2017
  • Deliriant
    Mandragora officinarum (Mandrake) Responsible use Hallucinogens Psychedelics Dissociatives Duncan, D., Gold, R. (1982). Drugs and the Whole Person. John Wiley
    11 KB (1,021 words) - 23:00, 21 April 2024
  • Dissociatives
    From PCP to MXE: A comprehensive review of the non-medical use of dissociative drugs. Drug Testing and Analysis, 6(7–8), 614–632. https://doi.org/10.1002/dta
    12 KB (1,097 words) - 02:41, 12 May 2024
  • Entactogen
    IBF5MAP MBDB MDA MDAI MDEA MDMA Mephedrone Methylone MMA MMDA PMA PMMA Responsible use Stimulants Psychedelics Empathy, love, and sociability enhancement MDMA
    6 KB (767 words) - 05:26, 22 September 2023
  • Opioids
    one use harm reduction practices when using this class of substances. Due to the highly euphoric nature of these substances, the recreational use and abuse
    19 KB (2,797 words) - 02:47, 12 May 2024
  • Psychedelic (redirect from Psychedelic drug)
    J. W. (2017). Psychedelic drug use in healthy individuals: A review of benefits, costs, and implications for drug policy. Drug Science, Policy and Law,
    31 KB (3,363 words) - 22:58, 21 April 2024
  • Psychonautics (category PsychonautWiki) (section Distinction from recreational substance use)
    those of ordinary recreational drug use. While typically viewed as some of the most powerful tools for such purposes, the use of mind-altering substances
    8 KB (886 words) - 22:58, 21 April 2024
  • NBx
    N-benzylphenethylamines are not habit-forming and the desire to use them can actually decrease with use. They are thought to be most often self-regulating. Some
    27 KB (1,991 words) - 18:31, 18 September 2022
  • 2C-T-2 (category PsychonautWiki articles needing factual verification from October 2020)
    Toxicity and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational 2C-T-2 use do not seem to have been
    22 KB (2,627 words) - 23:08, 29 May 2021
  • Thienodiazepines
    exhibit withdrawal symptoms with a slow onset and extended duration. Responsible use Depressant Benzodiazepine GABA Thienodiazepine (Wikipedia) Risks of
    11 KB (1,081 words) - 14:57, 27 July 2022
  • Stimulants
    MDEA (MDE) MDMA Methylone (βk-MDMA) PMA PMMA 5-APB 5-MAPB 6-APB 6-APDB Responsible use Psychoactive substance index Entactogens Nootropics Depressants Hallucinogens
    11 KB (1,055 words) - 02:52, 12 May 2024
  • Methoxetamine
    Toxicity and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational MXE use do not seem to have been studied
    23 KB (2,917 words) - 00:54, 19 September 2023
  • Nootropic
    Tianeptine Responsible use Psychoactive substance index Entactogens Stimulants Depressants Hallucinogens Nootropic (Wikipedia) Nootropics / Smart Drugs (Erowid)
    6 KB (658 words) - 23:00, 21 April 2024
  • Benzodiazepines (section Medical uses)
    Benzodiazepines have a unique history in that they were responsible for the largest-ever class-action lawsuit against drug manufacturers in the United Kingdom, involving
    28 KB (3,429 words) - 03:46, 9 May 2024
  • Tramadol
    strongly recommended that one use harm reduction practices when using this drug. As with other opioids, the chronic use of tramadol can be considered moderately
    22 KB (3,211 words) - 19:11, 7 April 2024
  • Alcohol (redirect from Alcohol use disorder) (category Pages with citations using unsupported parameters) (section Recreational use)
    generally discourage the use or consumption of alcohol. Spiritual: See the spiritual section. Recreational use: Recreational drug use of alcohol in moderation
    95 KB (11,688 words) - 02:47, 12 May 2024
  • Needle distribution programs (category Responsible drug use)
    Diego, CA 92104. Safer injection guide Sharing injection materials Responsible use Routes of administration North America Syringe Exchange Network Javed
    1 KB (230 words) - 19:22, 3 September 2022
  • ΑMT
    Toxicity and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational αMT use do not seem to have been studied
    25 KB (2,825 words) - 16:14, 28 November 2022
  • Cocaine
    cocaine use but is unlikely to arise from typical medical use. Tolerance to many of the effects of cocaine develops with prolonged and repeated use. This
    47 KB (6,322 words) - 08:08, 3 May 2024
  • Mescaline
    one use harm reduction practices when using this substance. Mescaline is not habit-forming, and the desire to use it can actually decrease with use. It
    35 KB (3,957 words) - 06:11, 30 June 2022
  • Rolicyclidine
    Erowid Experience Vaults: PCP Further information: Responsible use § Hallucinogens The long-term use of substances of the PCP class may lead to schizophrenia-like
    21 KB (2,634 words) - 00:21, 11 December 2023
  • Ayahuasca
    one use harm reduction practices when using this substance. Ayahuasca is not habit-forming, and the desire to use it can actually decrease with use. It
    33 KB (3,884 words) - 07:33, 16 November 2023
  • Methaqualone
    Verzeichnis A. Medicinal use is permitted. United Kingdom: Methaqualone is a Class B drug. United States: Methaqualone is a Schedule I drug, and is illegal to
    12 KB (1,829 words) - 23:50, 21 April 2024
  • GHB
    time the drug was used for. Light to moderate users often experience anxiety, insomnia, sleep-related problems, and tremors whereas heavy use can cause
    35 KB (4,460 words) - 13:32, 16 April 2024
  • Methylone
    Psychosis very rarely arises from therapeutic use. Warning: Many psychoactive substances that are reasonably safe to use on their own can suddenly become dangerous
    19 KB (2,841 words) - 14:21, 16 April 2024
  • 2C-E (category Pages using duplicate arguments in template calls)
    Class A drug in the United Kingdom as a result of the phenethylamine catch-all clause. United States: 2C-E is a Schedule I drug. Responsible use Volumetric
    22 KB (2,969 words) - 13:42, 16 April 2024
  • Methylphenidate
    false-positives for amphetamine in drug screenings. However, there was found no immunoassay cross reactivity in laboratory study. Responsible use Stimulants Amphetamine
    31 KB (4,254 words) - 15:15, 6 May 2024
  • Promethazine
    careful when trying this pharmaceutical and use responsible use practices such as always having a tripsitter when using promethazine, especially at high doses
    12 KB (1,621 words) - 00:22, 6 May 2024
  • Adrenaline (section Drugs targeting the adrenergic system)
    settings such as a school for emergency usage or for first aid carry. Responsible use Acetylcholine Dopamine Glutamate Serotonin Noradrenaline GABA Neurotransmitter
    5 KB (628 words) - 23:12, 21 April 2024
  • 3C-P
    that one use harm reduction practices when using this substance. 3C-P is not habit-forming, and the desire to use it can actually decrease with use. It is
    11 KB (1,643 words) - 00:24, 10 May 2024
  • Barbiturates
    barbiturates after prolonged use.[citation needed] It is unknown exactly how long it takes for tolerance to reach baseline after continued use. All barbiturates present
    16 KB (1,815 words) - 09:25, 14 January 2023
  • Caffeine
    strongly recommended that one use harm reduction practices when using this substance. Caffeine produces dependence with chronic use and has a low abuse potential
    29 KB (3,603 words) - 00:00, 10 May 2024
  • 4-MeO-PCP
    recommended that one use harm reduction practices when using this drug. As with other NMDA receptor antagonists, the chronic use of 4-MeO-PCP can be considered
    13 KB (1,828 words) - 21:19, 21 July 2022
  • 4-AcO-MET
    one use harm reduction practices when using this substance. 4-AcO-MET is not habit-forming and the desire to use it can actually decrease with use. It
    14 KB (2,059 words) - 17:03, 17 March 2024
  • 4-AcO-DET
    as drug and is illegal to possess, produce, supply, or import. United Kingdom: 4-AcO-DET is a Class A drug in the UK as it is an ester of the drug 4-HO-DET
    16 KB (2,204 words) - 05:15, 30 June 2022
  • Oxycodone
    strongly recommended that one use harm reduction practices when using this drug. As with other opioids, the chronic use of oxycodone can be considered
    17 KB (2,820 words) - 14:12, 16 April 2024
  • Cannabis (section Medical use)
    1961 drug convention signed by countries from around the world. Responsible use Hallucinogens Cannabinoids Synthetic cannabinoids Cannabis (drug) (Wikipedia)
    65 KB (8,816 words) - 18:09, 27 April 2024
  • 4-HO-DPT
    strongly recommended that one use harm reduction practices when using this drug. 4-HO-DPT is not habit-forming, and the desire to use it can actually decrease
    11 KB (1,524 words) - 16:45, 29 May 2021
  • 25E-NBOH (section Drug interactions)
    process, or distribute without a license from the Drug Enforcement Administration (DEA). Responsible use Psychedelic Phenethylamines 25B-NBOH 25X-NBOH 25E-NBOH
    17 KB (2,234 words) - 18:19, 30 April 2024
  • Psilocin
    recommended that one use harm reduction practices if choosing to use this substance. Psilocin is not habit-forming, and the desire to use it can actually decrease
    40 KB (4,715 words) - 16:45, 25 January 2024
  • Memantine
    Memantine Further information: Responsible use § Hallucinogens The toxicity and long-term health effects of recreational memantine use do not seem to have been
    17 KB (2,270 words) - 05:20, 1 May 2024
  • Deschloroketamine
    Austria under the NPSV (Neue-Psychoaktive-Substanzen-Verordnung). Responsible use Designer drug Dissociative O-PCE Ketamine MXE Deschloroketamine (Wikipedia)
    16 KB (2,011 words) - 23:32, 21 April 2024
  • Ephenidine
    Schedule IV drug. However, the isomer clauses within the legal text of the Schedules have rarely, if ever, been used for prosecution. Responsible use Research
    25 KB (3,096 words) - 09:43, 10 May 2024
  • Diphenhydramine
    [citation needed] The recreational use of diphenhydramine is generally not advised. If deciding to use this substance, one should use extreme caution and harm reduction
    33 KB (4,164 words) - 20:42, 12 May 2024
  • 2M2B
    produce, supply, or import this drug under the Psychoactive Substance Act, which came into effect on May 26th, 2016. Responsible use Depressant Alcohol GHB GBL
    10 KB (1,665 words) - 19:06, 3 May 2023
  • Diphenidine
    and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational diphenidine use do not appear to have been
    20 KB (2,560 words) - 20:28, 17 January 2024
  • 2C-I
    Toxicity and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational 2C-I use do not seem to have been studied
    19 KB (2,571 words) - 21:32, 14 November 2023
  • Myristicin
    in the United Kingdom, however, using it recreationally or extracting the myristicin is against the law. Responsible use Deliriants Tropane alkaloids Datura
    19 KB (2,523 words) - 07:09, 16 November 2023
  • 1,4-Butanediol
    drink out of. It is strongly recommended that one use harm reduction practices when using this drug. In multiple studies, GHB has been found to impair
    19 KB (2,729 words) - 17:49, 20 March 2024
  • Dextromethorphan
    extraction Further information: Responsible use § Hallucinogens The toxicity and long-term health effects of recreational DXM use in humans has not been studied
    66 KB (8,370 words) - 12:29, 7 May 2024
  • MDA
    Netherlands United Kingdom: MDA is a class A drug.[citation needed] United States: MDA is a Schedule I drug. Responsible use Entactogen Amphetamine MDMA MDEA 6-APB
    31 KB (4,379 words) - 12:23, 6 May 2024
  • 3-MeO-PCMo
    and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational 3-MeO-PCMo use do not seem to have been
    15 KB (2,255 words) - 21:04, 21 July 2022
  • Bufotenin
    that one use harm reduction practices when using this drug. Bufotenin is not habit-forming and the desire to use it can actually decrease with use. It is
    16 KB (2,273 words) - 19:54, 7 April 2024
  • LSD
    Zentner, Joseph L. (1976). "The Recreational Use of LSD-25 and Drug Prohibition". Journal of Psychedelic Drugs. 8 (4): 299–305. doi:10.1080/02791072.1976
    100 KB (12,100 words) - 08:20, 3 January 2024
  • Ketamine (section Caution for intravenous use)
    Category 3 drug in Mexico.[citation needed] New Zealand: Ketamine is a Class C drug in New Zealand.[citation needed] Norway: Ketamine is a Class A drug in Norway
    57 KB (7,569 words) - 21:34, 6 May 2024
  • 2-Fluorodeschloroketamine
    recommended that one use harm reduction practices when using this drug. As with other NMDA receptor antagonists, the chronic use of 2-Fluorodeschloroketamine
    17 KB (2,196 words) - 10:23, 7 May 2024
  • 4-HO-MPT
    and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational 4-HO-MPT use do not seem to have been
    10 KB (1,423 words) - 17:12, 29 May 2021
  • Omberacetam
    medical and pharmacological effects of this officially non-drug substance. Responsible use Nootropic Stimulant Modafinil Omberacetam (Wikipedia) Omberacetam
    11 KB (1,343 words) - 23:24, 21 April 2024
  • Alprazolam
    Misuse of Drugs Act 1971 makes it illegal to possess the drug without a prescription and, for such purposes, it is classified as a Class C drug. United States:
    25 KB (3,914 words) - 14:31, 16 April 2024
  • 4-AcO-MiPT
    strongly recommended that one use harm reduction practices when using this drug. 4-AcO-MiPT is not habit-forming and the desire to use it can actually decrease
    16 KB (2,243 words) - 18:21, 19 January 2024
  • Haloperidol
    that one use harm reduction practices when using this drug. Australia: The drug is available via prescription only.[citation needed] Canada: The drug is available
    8 KB (955 words) - 03:21, 11 May 2024
  • Heroin
    alth/drug-law-reform Vancouver Insite drug-injection facility can stay open, 2011  http://scc.lexum.org/en/2011/2011scc44/2011scc44.html New drug guidelines
    27 KB (4,225 words) - 13:14, 16 April 2024
  • 2C-T
    Toxicity and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational 2C-T use do not seem to have been studied
    13 KB (1,528 words) - 23:08, 29 May 2021
  • 2C-T-7
    potential, and Responsible use § Hallucinogens As of August 2007, there have been at least three reported deaths associated with the use of 2C-T-7. These
    22 KB (2,709 words) - 23:09, 29 May 2021
  • Naloxone
    prescription drug, but drug services can supply it without a prescription. And anyone can use it to save a life in an emergency. Responsible use Safer injection
    16 KB (2,164 words) - 23:20, 19 December 2022
  • Baclofen
    physical dependence with chronic use. Once physical dependence to a GABAergic substance occurs, the user cannot stop use abruptly without risking withdrawal
    16 KB (1,962 words) - 02:04, 19 March 2024
  • GBL
    drink out of. It is strongly recommended that one use harm reduction practices when using this drug. GBL itself may also produce neurotoxic effects, in
    31 KB (4,056 words) - 14:18, 16 April 2024
  • Zolpidem
    as a Schedule IV drug due to evidence that the drug has addictive properties similar to benzodiazepines.[citation needed] Responsible use Hallucinogens Deliriants
    28 KB (3,363 words) - 23:52, 21 April 2024
  • 25B-NBOH
    of Justice. November 18, 2021. p. 1. Drug control: Highlights of P.L. 99-570, Anti Drug Abuse Act of 1986: (drug-related provisions only) (1986). bill
    19 KB (2,736 words) - 09:31, 8 April 2024
  • Modafinil
    substance. It is illegal to buy, sell, or possess the drug without a prescription or DEA license. Responsible use Nootropics Stimulants Armodafinil Caffeine Modafinil
    19 KB (3,104 words) - 11:29, 16 April 2024
  • 25C-NBOH
    Kingdom: 25C-NBOH is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause. Responsible use Research chemical Psychedelics
    19 KB (2,640 words) - 07:18, 30 June 2022
  • Codeine
    strongly recommended that one use harm reduction practices when using this drug. As with other opioids, the chronic use of codeine can be considered moderately
    27 KB (4,327 words) - 13:58, 16 April 2024
  • Morphine
    Morphine is listed as a Class A drug under the Misuse of Drugs Act 1971 and a Schedule 2 Controlled Drug under the Misuse of Drugs Regulations 2001. United States:
    27 KB (4,071 words) - 14:39, 16 April 2024
  • Quetiapine (section Medical uses)
    than other more commonly used antipsychotics. It is strongly recommended that one use harm reduction practices when using this drug. Compared to other antipsychotics
    26 KB (3,070 words) - 00:36, 28 April 2024
  • DOC
    Toxicity and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational DOC use do not seem to have been studied
    23 KB (3,384 words) - 19:08, 13 February 2022
  • DPT
    that one use harm reduction practices when using this substance. DPT is not habit-forming and the desire to use it can actually decrease with use. As with
    22 KB (2,679 words) - 15:39, 28 January 2023
  • Psilocybin mushrooms
    adults age 21 and older. Italy: Psilocybin is a schedule I drug (Tabella 1). Responsible use Entheogen Psychedelic Tryptamine DMT LSD Mescaline Psilocybin
    67 KB (8,112 words) - 22:04, 6 May 2024
  • 5-MeO-DiPT
    Toxicity and harm potential, and Responsible use § Hallucinogens The long-term health effects of recreational 5-MeO-DiPT use do not seem to have been studied
    16 KB (2,115 words) - 09:35, 3 September 2022
  • Amanita muscaria
    produce, supply, or import this drug under the Psychoactive Substance Act, which came into effect on May 26th, 2016. Responsible use Naturally occurring sources
    16 KB (1,938 words) - 23:10, 21 April 2024
  • 4-HO-MET
    one use harm reduction practices when using this substance. 4-HO-MET is not habit-forming, and the desire to use it can actually decrease with use. It
    24 KB (3,279 words) - 18:46, 12 November 2022
  • 4-AcO-DMT
    or the use for non-medical or research purposes could be prosecuted as crimes under the Federal Analogue Act.[citation needed] Responsible use Psychedelic
    30 KB (4,417 words) - 23:36, 21 April 2024
  • DOB
    recommended that one use harm reduction practices when using this substance. DOB is not habit-forming, and the desire to use it can decrease with use. It is most
    21 KB (2,972 words) - 17:25, 26 January 2023
  • 4-HO-EPT
    and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational 4-HO-EPT use do not seem to have been
    9 KB (1,364 words) - 16:46, 29 May 2021
  • 25I-NBOH
    Kingdom: 25I-NBOH is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause. Responsible use Research chemical Psychedelics
    19 KB (2,665 words) - 20:05, 19 July 2022
  • Mephedrone
    strongly recommended that one use harm reduction practices when using this drug. As with other stimulants, the chronic use of mephedrone can be considered
    29 KB (3,963 words) - 14:23, 16 April 2024
  • 5-MeO-DMT
    as drug and is illegal to possess, produce, supply, or import. United Kingdom: 5-MeO-DMT is a Class A drug in the UK as it is an ether of the drug 5-HO-DMT
    26 KB (3,619 words) - 19:56, 7 April 2024
  • 3-MMC
    categorized by the DEA as a Schedule I Positional Isomer. [1] Responsible use Designer drug Substituted cathinone Stimulants Entactogens Mephedrone (4-MMC)
    18 KB (2,590 words) - 21:20, 30 April 2024
  • Hydrocodone
    strongly recommended that one use harm reduction practices when using this drug. As with other opiate-based painkillers, the chronic use of hydrocodone can be
    15 KB (2,654 words) - 23:50, 21 April 2024
  • 2C-T-21
    may therefore be considered a Schedule I drug under the Federal Analogue Act.[citation needed] Responsible use Volumetric dosing Research chemical MAOI
    18 KB (2,002 words) - 06:06, 12 August 2022
  • 4-HO-DET
    one use harm reduction practices when using this substance. 4-HO-DET is not habit-forming and the desire to use it can actually decrease with use. It is
    13 KB (1,850 words) - 11:44, 26 February 2024
  • 2C-D
    that one use harm reduction practices when using this substance. 2C-D is not habit-forming and the desire to use it can actually decrease with use. It is
    21 KB (2,868 words) - 17:39, 18 January 2024
  • 4-HO-DiPT
    strongly recommended that one use harm reduction practices when using this drug. 4-HO-DiPT is not habit-forming, and the desire to use it can actually decrease
    12 KB (1,670 words) - 16:44, 29 May 2021
  • 5-MeO-MiPT
    that one use harm reduction practices when using this drug. 5-MeO-MiPT is not habit-forming, and the desire to use it can actually decrease with use. It is
    22 KB (2,938 words) - 21:31, 14 November 2023
  • Phencyclidines
    a combination of two or more substances is safe before consumption. Responsible use Dissociative Ketamine Methoxetamine NMDA receptor antagonist Arylcyclohexylamine
    5 KB (764 words) - 03:32, 5 February 2020
  • Harmala alkaloid (section Drug interactions)
    recommended that one use harm reduction practices when using this drug. There is no tolerance built up with harmala alkaloid use. There are no real reports
    13 KB (1,772 words) - 02:21, 24 September 2023
  • 1P-ETH-LAD
    one use harm reduction practices when using this substance. 1P-ETH-LAD is not habit-forming and the desire to use it can actually decrease with use. Like
    17 KB (2,371 words) - 16:28, 29 May 2021
  • DOM
    United States: DOM is a Schedule I drug.[citation needed] Czech Republic: DOM is a Schedule I drug. Responsible use Psychedelics Phenethylamines DOx DOC
    24 KB (3,112 words) - 15:32, 12 April 2023
  • Mirtazapine
    legal import of the medicine for personal use as outlined in Section 13 of the Medicines Act 1968. Responsible use Hallucinogen Psychedelic Deliriant Mirtazapine
    32 KB (3,698 words) - 18:07, 7 April 2024
  • Phenibut
    substance. Latvia: Phenibut is an unscheduled prescription drug, marketed as "Noofen". Responsible use Depressant Gabapentinoid GABA F-Phenibut Gabapentin Pregabalin
    22 KB (2,703 words) - 18:36, 26 August 2023
  • 2C-C
    Toxicity and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational 2C-C use do not appear to have been
    22 KB (3,030 words) - 21:29, 14 November 2023
  • Salvinorin A
    Further information: Responsible use § Hallucinogens The toxicity and long-term health effects of recreational salvinorin A use do not seem to have been
    26 KB (3,526 words) - 00:46, 27 February 2024
  • Ibogaine
    Chemicals" (PDF). Drug Enforcement Administration (DEA). August 2020.  Doug McVay, ed. (June 9, 2020). "Ibogaine". Drug War Facts. Common Sense for Drug Policy.
    28 KB (3,126 words) - 11:42, 16 April 2024
  • Diazepam
    prescription and, for such purposes, it is classified as a Class C drug. Responsible use Volumetric liquid dosing Depressants Benzodiazepines Diclazepam Diazepam
    34 KB (4,165 words) - 14:05, 16 April 2024
  • 2-Aminoindane
    strongly recommended that one use harm reduction practices when using this drug. As with other stimulants, the chronic use of 2-AI can be considered moderately
    12 KB (1,928 words) - 23:42, 21 April 2024
  • 2-FMA
    considered a narcotic and is illegal. Responsible use Research chemical Stimulant Substituted amphetamine Lisdexamfetamine 2-FA Methamphetamine 2-Fluoromethamphetamine
    17 KB (2,934 words) - 17:24, 18 January 2024
  • 2-FEA
    E point 130. It is legal when used for scientific or industrial use. United Kingdom: 2-FEA is considered a Class A drug as a result of the amphetamine
    13 KB (1,917 words) - 18:16, 30 April 2024
  • 2C-P
    Toxicity and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational 2C-P use do not seem to have been studied
    22 KB (3,193 words) - 17:38, 18 January 2024
  • Clonazepam
    Kingdom: Clonazepam is a Class C drug. United States: Clonazepam is a Schedule IV substance.[citation needed] Responsible use Psychoactive substance index
    20 KB (2,574 words) - 20:48, 7 April 2024
  • EPT
    Toxicity and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational EPT use have not been studied in any
    9 KB (1,156 words) - 05:07, 30 June 2022
  • 4-HO-MiPT
    one use harm reduction practices when using this substance. 4-HO-MiPT is not habit-forming, and the desire to use it can actually decrease with use. It
    23 KB (3,192 words) - 12:43, 2 May 2022
  • Allylescaline
    one use harm reduction practices when using this drug. Allylescaline is not habit-forming, and the desire to use it can actually decrease with use. It
    10 KB (1,076 words) - 12:09, 2 May 2022
  • 1P-LSD
    Toxicity and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational 1P-LSD use have not been studied. This
    36 KB (4,688 words) - 09:41, 10 May 2024
  • Lisdexamfetamine (category Pages with citations using unsupported parameters)
    recommended that one use harm reduction practices when using this drug. Addiction is a serious risk with heavy recreational amphetamine use but is unlikely
    23 KB (3,617 words) - 09:16, 17 April 2024
  • 2-FA
    strongly recommended that one use harm reduction practices when using this drug. As with other stimulants, the chronic use of 2-FA can be considered moderately
    17 KB (3,024 words) - 17:25, 18 January 2024
  • Fentanyl
    strongly recommended that one use harm reduction practices when using this substance. As with other opioids, the chronic use of fentanyl can be considered
    21 KB (3,331 words) - 23:49, 21 April 2024
  • DiPT
    is strongly recommended that one use harm reduction practices when using this drug. As with many psychedelics, the use of DiPT has the potential to bring
    14 KB (1,730 words) - 21:48, 16 January 2023
  • MET
    Toxicity and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational MET use do not seem to have been studied
    13 KB (1,611 words) - 15:10, 10 March 2023
  • Gabapentin
    with gabapentin use. In 2010, a study conducted by Patorno E, Bohn RL, Wahl PM, et al, found that the use of gabapentin compared to the use of topiramate
    23 KB (2,828 words) - 23:50, 21 April 2024
  • Methoxphenidine
    Toxicity and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational MXP use do not seem to have been studied
    21 KB (2,841 words) - 20:14, 22 July 2022
  • O-PCE
    clause added to the Misuse of Drugs Act by S.I. 2013/239, which came into effect on the 26th February 2013. Responsible use Volumetric dosing Research chemical
    16 KB (2,133 words) - 17:21, 17 March 2024
  • Ethylphenidate
    strongly recommended that one use harm reduction practices when using this substance. As with other stimulants, the chronic use of ethylphenidate can be considered
    18 KB (2,561 words) - 14:02, 16 April 2024
  • Cannabidiol (section Medical use)
    the potential to cause adverse drug-drug interactions. As a result, it is advised to use harm reduction practices if using this substance. Cannibidiol was
    23 KB (2,978 words) - 07:22, 8 April 2023
  • 3C-E
    that one use harm reduction practices when using this substance. 3C-E is not habit-forming, and the desire to use it can actually decrease with use. It is
    15 KB (2,058 words) - 05:50, 30 June 2022
  • Tripsitting index (category PsychonautWiki)
    syndrome. MDMA-AP Serotonin syndrome treatment: Common Psychonautics Responsible use Psychoactive substance index Subjective effect index Project:Comparison
    905 bytes (619 words) - 20:57, 24 April 2023
  • Zopiclone
    Zopiclone, like all "Z-drugs", is recommended to be taken on a short-term basis -- usually a week or less. Daily or continuous use of the drug is usually not advised
    16 KB (2,144 words) - 01:23, 20 April 2024
  • 6-APDB
    § Toxicity and harm potential, and Responsible use § Hallucinogens Due to only having a short history of human use, the toxicity and harm potential is
    26 KB (4,015 words) - 23:44, 21 April 2024
  • Pramiracetam
    effects. It is strongly recommended that one use harm reduction practices when using this substance. The chronic use of Pramiracetam can be considered as not
    8 KB (1,030 words) - 20:10, 2 August 2022
  • Piracetam
    but is used off-label for other conditions. In the United States, it is not approved by the Food and Drug Administration for any medical use and it is
    12 KB (1,475 words) - 00:39, 15 April 2023
  • 2C-B-FLY
    one use harm reduction practices when using this substance. 2C-B-FLY is not habit-forming, and the desire to use it can actually decrease with use. It
    21 KB (2,764 words) - 23:36, 21 April 2024
  • MPT
    that one uses harm reduction practices when using this drug. MPT is not habit-forming and the desire to use it can actually decrease with use. It is most
    11 KB (1,222 words) - 07:19, 14 July 2023
  • 3-FPM
    strongly recommended that one use harm reduction practices when using this substance. As with other stimulants, the chronic use of 3-FPM can be considered
    15 KB (2,265 words) - 06:42, 8 September 2023
  • Aniracetam
    safety, it is still strongly recommended that one use harm reduction practices when using this drug. The median lethal dosage (LD50) of aniracetam has
    11 KB (1,427 words) - 22:01, 24 January 2024
  • Nicotine (category Pages with citations using unsupported parameters)
    Tobacco products are legal, but their public use is restricted to specific smoke-friendly areas. Responsible use Stimulants Substituted pyrrolidine Nicotine
    53 KB (5,335 words) - 06:57, 15 May 2024
  • DET
    information: Research chemicals § Toxicity and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational
    14 KB (1,584 words) - 04:58, 30 June 2022
  • A-PHP (category Pages with citations using unnamed parameters)
    July 18, 2022. . As such, the sale or the use of this compound is prohibited. Responsible use Designer drug Stimulants Substituted cathinone Substituted
    21 KB (3,212 words) - 09:58, 30 May 2023
  • Guidelines (category PsychonautWiki) (section What should be on this wiki)
    person: use "the individual", "the user", or "one" instead of "you." Please become acquainted with the Wiki markup/formatting. Please do not use dangling
    13 KB (1,315 words) - 23:14, 21 April 2024
  • LSZ
    that one use harm reduction practices when using this substance. LSZ is not habit-forming and the desire to use it can actually decrease with use. It is
    14 KB (1,746 words) - 04:58, 2 December 2022
  • MXiPr
    Toxicity and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational MXiPr use do not seem to have been studied
    17 KB (2,265 words) - 18:27, 14 January 2024
  • MiPT
    is strongly recommended that one use harm reduction practices when using this drug. As with many psychedelics, the use of MiPT has the potential to bring
    11 KB (1,201 words) - 22:54, 17 September 2023
  • 4-AcO-DiPT
    recommended that one use harm reduction practices when using this drug. 4-AcO-DiPT is not known to be habit-forming and the desire to use it can actually decrease
    22 KB (3,080 words) - 05:46, 30 June 2022
  • Melatonin
    distribute, and is freely available to purchase as a dietary supplement. Responsible use Oneirogen Neurotransmitter Hormone Tryptamine Melatonin (Wikipedia)
    15 KB (1,896 words) - 23:12, 21 April 2024
  • 3-FEA
    intended for human consumption.[citation needed] Responsible use Designer drug Entactogen Stimulants Substituted amphetamines 4-FA 3-FA 3-FMA 3-FEA (Wikipedia)
    19 KB (3,317 words) - 15:23, 30 July 2022
  • Adrafinil
    prolonged use and have been associated with Adrafinil, specifically. It is strongly recommended that one use harm reduction practices when using this substance
    7 KB (852 words) - 19:06, 2 August 2022
  • Kratom
    1928. Responsible use Psychoactive substance index Opioids Stimulants Kratom (Wikipedia) Kratom (Erowid Vault) Kratom (Drugs.com) Kratom (Drugs-Forum)
    42 KB (6,087 words) - 13:21, 16 April 2024
  • Bromo-DragonFLY
    information related to the use of this compound should be received with extreme caution. It is strongly recommended that one use the utmost harm reduction
    20 KB (2,786 words) - 23:37, 21 April 2024
  • AL-LAD
    Toxicity and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational AL-LAD use do not seem to have been
    30 KB (4,063 words) - 04:16, 30 June 2022
  • 1V-LSD
    Toxicity and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational 1V-LSD use have not been studied. This
    28 KB (3,658 words) - 15:27, 10 March 2023
  • Pregabalin (section Medical uses)
    recreational use, tolerance development and addiction. Sweden: Pregabalin is a prescription drug. classified as a controlled substance, as a schedule V drug, since
    41 KB (5,211 words) - 12:50, 15 March 2024
  • Isopropylphenidate
    strongly recommended that one use harm reduction practices when using this drug. As with other stimulants, the chronic use of isopropylphenidate can be
    19 KB (2,684 words) - 18:04, 30 July 2022
  • 5-MeO-DALT
    one use harm reduction practices when using this substance. 5-MeO-DALT is not habit-forming, and the desire to use it can actually decrease with use. It
    16 KB (2,263 words) - 23:37, 21 April 2024
  • Tapentadol
    strongly recommended that one use harm reduction practices when using this drug. As with other opioids, the chronic use of tapentadol can be considered
    12 KB (2,182 words) - 23:51, 21 April 2024
  • ALD-52
    Toxicity and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational ALD-52 use do not appear to have been
    35 KB (4,592 words) - 06:53, 10 December 2023
  • A-PVP
    strongly recommended that one use harm reduction practices when using this substance. As with other stimulants, the chronic use of α-PVP can be considered
    24 KB (3,456 words) - 00:08, 3 November 2023
  • Hydromorphone
    strongly recommended that one use harm reduction practices when using this drug. As with other opiate-based painkillers, the chronic use of hydromorphone can be
    15 KB (2,521 words) - 19:28, 7 April 2024
  • Substituted tryptamines
    to as "unsubstituted tryptamines" or "base tryptamines" Tryptamine Responsible use Lysergamide TiHKAL Entheogen Phenethylamine Substituted tryptamine (Wikipedia)
    10 KB (461 words) - 23:05, 21 April 2024
  • Phenylpiracetam
    produce, supply, or import this drug under the Psychoactive Substance Act, which came into effect on May 26th, 2016. Responsible use Pramiracetam Oxiracetam Nootropic
    11 KB (1,273 words) - 00:25, 6 May 2024
  • TMA-2
    definition (TMA-2 is a positional isomer of the UN controlled drug TMA).[citation needed] Responsible use Research chemicals Psychedelics Phenethylamines Substituted
    14 KB (1,685 words) - 06:26, 30 June 2022
  • Buprenorphine
    strongly recommended that one use harm reduction practices when using this drug. As with other opioids, the chronic use of buprenorphine can be considered
    15 KB (2,602 words) - 23:49, 21 April 2024
  • Nitrous (category Pages with citations using unsupported parameters)
    from a whipping dispenser. Responsible use Inhalants Hallucinogen Dissociative Ketamine Nitrous Oxide (Wikipedia) Recreational use of nitrous oxide (Wikipedia)
    37 KB (4,981 words) - 01:27, 11 May 2024
  • DXM & DPH
    Dextromethorphan § Legality Main article: Diphenhydramine § Legality Responsible use Harm reduction DXM DPH Dextromethorphan (Wikipedia) Diphenhydramine
    24 KB (3,158 words) - 17:16, 6 July 2023
  • 4F-MPH
    is a Schedule I controlled substance in the state of Alabama. Responsible use Designer drug Stimulant Methylphenidate 4F-EPH 4F-MPH (Wikipedia) 4F-MPH (Isomer
    16 KB (2,465 words) - 15:45, 9 May 2024
  • Oxymorphone
    strongly recommended that one use harm reduction practices when using this drug. As with other opiate-based painkillers, the chronic use of oxymorphone can be
    12 KB (2,163 words) - 02:26, 8 April 2023
  • PMMA
    Kingdom: PMMA is a Class A drug.[citation needed] United States: PMMA is a Schedule I drug as of July 26th, 2021. Responsible use Research chemical Substituted
    10 KB (1,254 words) - 09:30, 28 December 2022
  • AB-FUBINACA
    important to use proper precautions when dosing to avoid a negative experience. It is strongly recommended that one use harm reduction practices when using this
    17 KB (2,112 words) - 00:41, 23 July 2022
  • LSA
    (CWE) Further information: Responsible use § Hallucinogens The toxicity and long-term health effects of recreational LSA use have not been studied in any
    29 KB (3,883 words) - 13:23, 16 April 2024
  • Methadone
    strongly recommended that one use harm reduction practices when using this drug. As with other opioids, the chronic use of methadone can be considered
    17 KB (2,924 words) - 23:50, 21 April 2024
  • 3-FA
    only if it is intended for human consumption.[citation needed] Responsible use Designer drug Stimulants Substituted amphetamine 2-FA 2-FMA 3-FEA 3-FA (Wikipedia)
    15 KB (2,726 words) - 11:39, 17 February 2024
  • PRO-LAD
    PRO-LAD is specifically named in the U.K. Misuse of Drugs Act as a Class A drug. Responsible use (Hallucinogens) Research chemical Hallucinogens Psychedelic
    21 KB (2,993 words) - 16:35, 29 May 2021
  • THJ-018
    important to use proper precautions when dosing to avoid a negative experience. It is strongly recommended that one use harm reduction practices when using this
    17 KB (2,278 words) - 01:35, 23 July 2022
  • 3-FMA
    strongly recommended that one use harm reduction practices when using this drug. Although it still remains to be seen, the chronic use of 3-FMA likely can be
    14 KB (2,687 words) - 15:28, 30 July 2022
  • Desoxypipradrol
    development after the related drug methylphenidate was developed by the same company. Methylphenidate was felt to be the superior drug for treating ADHD due to
    19 KB (2,776 words) - 00:39, 1 August 2022
  • ETH-LAD
    that one use harm reduction practices when using this substance. ETH-LAD is not habit-forming and the desire to use it can actually decrease with use. As with
    29 KB (3,987 words) - 04:34, 30 June 2022
  • Ethylmorphine
    strongly recommended that one use harm reduction practices when using this drug. As with other opioids, the chronic use of ethylmorphine can be very addictive
    12 KB (2,094 words) - 08:25, 10 May 2024
  • Escaline
    one use harm reduction practices when using this substance. Escaline is not habit-forming, and the desire to use it can actually decrease with use. It
    12 KB (1,512 words) - 00:01, 21 December 2023
  • 3,4-CTMP
    (methylphenidate) under the Federal Analog Act.[citation needed] Responsible use Volumetric dosing Designer drug Stimulant Methylphenidate 4F-MPH 4F-EPH 3,4-CTMP (Wikipedia)
    24 KB (3,701 words) - 23:42, 21 April 2024
  • Carisoprodol
    effects and abuse. It is strongly recommended that one use harm reduction practices when using this drug. Carisoprodol is extremely physically and psychologically
    7 KB (1,241 words) - 01:02, 17 August 2023
  • TMA-6
    Toxicity and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational TMA-6 use do not seem to have been studied
    12 KB (1,570 words) - 21:03, 19 July 2022
  • Oxiracetam
    produce, supply, or import this drug under the Psychoactive Substance Act, which came into effect on May 26th, 2016. Responsible use Pramiracetam Nootropic Stimulant
    9 KB (1,148 words) - 19:58, 2 August 2022
  • 4F-EPH
    strongly recommended that one use harm reduction practices when using this drug. As with other stimulants, the chronic use of 4F-EPH can be considered moderately
    17 KB (2,757 words) - 17:49, 30 July 2022
  • JWH-018
    strongly recommended that one use harm reduction practices when using this drug. As with other synthetic cannibanoids, the chronic use of JWH-018 can be considered
    25 KB (3,199 words) - 21:56, 28 October 2023
  • Dextroamphetamine
    United States, citing several dextroamphetamine prescription drugs as examples. Responsible use Stimulant Amphetamine Enantiomers Levoamphetamine Amphetamines
    5 KB (1,411 words) - 18:49, 5 May 2024
  • Proscaline
    trying this drug, but nothing can be completely guaranteed. It is strongly recommended that one use harm reduction practices when using this drug. Proscaline
    10 KB (1,076 words) - 21:01, 29 May 2021
  • 5-APB
    Analogue Act if intended for human consumption.[citation needed] Responsible use Designer drug Entactogen Stimulant 5-MAPB 6-APB MDA 5-APB (Wikipedia) 5-APB
    14 KB (2,336 words) - 23:43, 21 April 2024
  • O-Desmethyltramadol
    strongly recommended that one use harm reduction practices when using this drug. As with other opioids, the chronic use of O-DSMT can be considered moderately
    13 KB (2,437 words) - 07:14, 27 December 2023
  • 5-MAPB
    the Federal Analogue Act if intended for human consumption. Responsible use Designer drug Entactogens Stimulants 5-APB 6-APB MDAI MDA MDMA 5-MAPB (Wikipedia)
    13 KB (2,233 words) - 00:32, 31 December 2022
  • 5F-AKB48
    important to use proper precautions when dosing to avoid a negative experience. It is strongly recommended that one use harm reduction practices when using this
    17 KB (2,169 words) - 00:20, 23 July 2022
  • Prochlorperazine
    recommended that one use harm reduction practices when using this drug. As with other antipsychotics, dependence can be present with long-term use and is both physical
    6 KB (748 words) - 19:29, 30 April 2024
  • 1cP-LSD
    and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational 1cP-LSD use have not been studied. This
    27 KB (3,642 words) - 18:48, 12 November 2022
  • MDEA
    Kingdom: MDEA is a Class A drug.[citation needed] United States: MDEA is a Schedule I drug.[citation needed] Responsible use Entactogen Stimulant Phenethylamine
    25 KB (3,654 words) - 23:46, 21 April 2024
  • DOI
    Verzeichnis E point 130. It is legal when used for scientific or industrial use. Turkey: DOI is a classed as drug and is illegal to possess, produce, supply
    24 KB (3,353 words) - 23:37, 21 April 2024
  • PARGY-LAD
    PARGY-LAD is specifically named in the U.K. Misuse of Drugs Act as a Class A drug. Responsible use (Hallucinogens) Psychoactive substance index Research
    18 KB (2,500 words) - 18:47, 11 January 2023
  • Dihydrocodeine
    strongly recommended that one use harm reduction practices when using this drug. As with other opioids, the chronic use of dihydrocodeine can be considered
    18 KB (3,071 words) - 19:24, 7 April 2024
  • Hexedrone
    strongly recommended that one use harm reduction practices when using this drug. As with other stimulants, the chronic use of Hexedrone can be considered
    8 KB (961 words) - 23:45, 21 April 2024
  • 5F-PB-22
    important to use proper precautions when dosing to avoid a negative experience. It is strongly recommended that one use harm reduction practices when using this
    18 KB (2,421 words) - 00:31, 23 July 2022
  • Eszopiclone
    do. Possession without a prescription can lead to drug charges. Responsible use Depressants Z-drugs Benzodiazepines Eszopiclone (Wikipedia) Zopiclone/Eszopiclone
    9 KB (1,257 words) - 18:31, 30 April 2024
  • Coluracetam
    Piracetam and Piracetam-Like Drugs. Drugs, 70(3), 287–312. https://doi.org/10.2165/11319230-000000000-00000 Responsible use Noopept Nootropic Stimulant
    10 KB (1,688 words) - 19:54, 2 August 2022
  • Βk-2C-B
    and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational βk-2C-B use do not seem to have been
    13 KB (1,619 words) - 06:10, 30 June 2022
  • Diclazepam
    rather than stopping use abruptly, as this can lead to severe, potentially life-threatening withdrawal symptoms. Diclazepam is a drug of the benzodiazepine
    23 KB (2,638 words) - 01:21, 6 February 2023
  • Flubromazepam
    alcohol or opioids. It is strongly recommended that one use harm reduction practices when using this drug. Flubromazepam is extremely physically and psychologically
    21 KB (2,428 words) - 21:38, 11 May 2023
  • Acetylfentanyl
    resurgence in use began in Estonia in the early 2000s. It is highly advised to use harm reduction practices such as volumetric dosing if choosing to use this substance
    22 KB (3,397 words) - 23:49, 21 April 2024
  • PMA
    United Kingdom: PMA is a Class A drug.[citation needed] United States: PMA is a Schedule I substance. Responsible use Substituted amphetamine Entactogen
    10 KB (2,183 words) - 19:02, 2 August 2022
  • Desomorphine
    strongly recommended that one use harm reduction practices when using this drug. As with other opiate-based painkillers, the chronic use of desomorphine can be
    24 KB (3,013 words) - 22:01, 27 July 2022
  • Clonazolam
    advised to use proper harm reduction practices if choosing to use this substance. Clonazolam is a drug of the benzodiazepine class. Benzodiazepine drugs contain
    22 KB (3,495 words) - 20:51, 7 April 2024
  • NM-2-AI
    strongly recommended that one use harm reduction practices when using this drug. As with other stimulants, the chronic use of NM-2-AI can be considered
    11 KB (1,914 words) - 23:46, 21 April 2024
  • APICA
    2016 and is illegal to possess, produce, supply, or import. Responsible use Designer drug Synthetic cannabinoids AKB48 STS-135 JWH-018 APICA (Wikipedia)
    17 KB (2,044 words) - 23:41, 21 April 2024
  • F-Phenibut
    substances" with exemptions for alcohol, nicotine and "medicinal products." Responsible use Research chemical Depressants Nootropics Phenibut Gabapentin GHB 4-Fluorophenibut
    12 KB (1,795 words) - 20:04, 18 November 2023
  • Oxazepam
    controlled drug under the Convention on Psychotropic Substances. Bromazepam is regulated in most countries as a prescription drug. Responsible use (List along
    11 KB (1,119 words) - 19:28, 2 December 2023
  • Bromazolam
    recommended that one use harm reduction practices when using this substance. Warning: Many psychoactive substances that are reasonably safe to use on their own
    16 KB (2,105 words) - 09:57, 11 March 2024
  • MDAI
    MDAI, and it has a limited history of human use. It is highly advised to use harm reduction practices if using this substance. MDAI, or 5,6-methylenedioxy-2-aminoindane
    17 KB (2,560 words) - 07:40, 12 October 2023
  • Dextropropoxyphene
    strongly recommended that one use harm reduction practices when using this drug. As with other opioids, the chronic use of dextropropoxyphene can be considered
    10 KB (2,015 words) - 23:49, 21 April 2024
  • 5-MeO-DiBF
    one use harm reduction practices when using this substance. 5-MeO-DiBF is not habit-forming, and the desire to use it can actually decrease with use. It
    11 KB (1,523 words) - 23:37, 21 April 2024
  • 3-Cl-PCP
    and harm potential, and Responsible use § Hallucinogens The toxicity and long-term health effects of recreational 3-Cl-PCP use have not been studied in
    15 KB (1,980 words) - 20:44, 21 July 2022

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from ‘https://psychonautwiki.org/wiki/Special:Search’